1. 2. 3. 4. 5.

Present Turover Market Presence Markets still to be penetrated Present field force Therapeutic segments

50 crores Since 30 years Delhi, Punjab, TN, Kerela 300 Gynaec, Paeds,Respiratory, Dermatology Since 3 years

6.

Sales in plateau stage

 Plan to reach Rs.100 crore plus business by 2012.

The 3 year journey from 50 crore to 100 crore would be a long and challenging one Accurate Planning, calculated Risks and Perfect execution would be the tools for success

Increase the customers Increase the prices

Increase the amount spend by customer in each transaction

Pharmaceutical industry, Indian in particular is a player in generics The product portfolio of the company seems to be impressive but due to competition it is not able to reap benefits. so the main changes should be process related modifications which involves almost no risk rather than 'business development' kind of thing which sounds nice on paper but has a greater unfavourable risk-benefit ratio.

 Penetrate

the already existing market deeper. Focusing on constantly increasing market Aggressive marketting Market research

Develop new markets Up gradation of existing products and their dispensing Acquisition of smaller companies

Having a widespread presence, specially the states like Tamil nadu, Kerala and Delhi circle. It will need a solid increase in field force but also market will increase. Focusing on indigenous medicine from alternative medicines

1. Financial strategy:

Selling its stakes to some outsiders in lieu of money. Financial borrowings can be from NBFC(non banking financial companies), or banks or through equity.

2. Marketing Strategy:

Company needs to employ its market presence which is for more than 3 decades in market. It should work upon Preserving the core and Introducing the new product. Increasing distributorship Entering the emerging lifestyle diseases market

2. Marketing Strategy: Nupur

Focus on niche market drugs rather than Blockbusters. DTC marketing. It can work upon Preserving the core and Introducing the new product. Increasing distributorship. Entering into new specialty therapeutic segments like Bio-similars , Oncology, Peptides and Limuses. These new growth areas will add significant depth to the existing product pipeline. Aggressive marketing strategy. In short term company can increase its sales force to increase awareness. Market research.

Product Portfolio:
Maintain and improve product quality An existing opportunity Antibiotics Focus should shift gradually to lifestyle disease prevention

R&D

Human Resource aspect:

HR is of utmost importance in a country like India where values take precedence over everything else.

Co. needs to work on its people's skills and strengths.

Doctors feedback forms can help reveal any holes in the company's HR strategy.

CHALLENGES:
They might sound very fruitful but they are not unless you are a major player with a deep pocket and have 5-6 years of focus for this kind of things: 1. Cost of R&D, 2. Focusing overseas market without caution 3. increase/favour materialistic input to doctors like sponsorship, CME etc. it can not compete with the big players in this front. 4. Launching product after product.

OUT OF THE BOX IDEAS

Establishing a Pharmaceutical college Focusing on Nutraceuticals Shifting the focus from Individual doctors to Hospitals per se PSP